January 20, 2022

FDA: Class I recall of Getinge Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems

By: Judy Mathias
Share

Editor's Note

The Food and Drug Administration (FDA) on January 19 identified the recall by Getinge of its Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems as Class I, the most serious.

The recall was initiated because of the potential chemical breakdown of Sevoflurane that may result in inhalation and/or skin exposure to harmful chemicals.

There have been eight complaints and no reported deaths or injuries.

Distribution dates were February 16, 2021 to October 30, 2021.

Read More >>
Live chat by BoldChat